In our study, the relationship between PBRM1 and the prognosis of immunotherapy in pan-cancer was comprehensively analyzed by combining the universal carcinomatous public cohort and our clinical data collected in the First Affiliated Hospital of Nanjing Medical University. The gene discussed is PBRM1; the disease is cancer.